Researchers have shown that infections with two different common human coronaviruses (HCoVs) don't generate antibodies that effectively cross-react with SARS-CoV-2. So, prior infection with HCoVs is ...
In a recent study posted to the bioRxiv* server, researchers reported that some monoclonal neutralizing antibodies (nAbs) directed against distinct receptor-binding domain (RBD) epitopes nested inside ...
Vaccines against coronavirus disease 2019 (COVID-19) developed and produced during the COVID-19 pandemic offer a significant degree of protection. However, after the second dose of a vaccine, ...
A recent study published in PLOS ONE investigated whether antibodies enhance severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Study: Anti-SARS-CoV-2 IgG and IgA antibodies in ...
Although SARS-CoV-2 has taken the world by storm, it’s not the only coronavirus that can infect humans. But unlike SARS-CoV-2, common human coronaviruses (HCoVs) generally cause only mild disease. Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback